Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
14 participants
OBSERVATIONAL
2021-08-26
2021-09-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pediatric Dysphagia Outcomes After Injection Laryngoplasty for Type I Laryngeal Cleft
NCT01507207
The Role of Vocal Rest After Removal of Benign Lesions From Vocal Cord
NCT03046706
'The Impact of Rhinovirus Infections in Paediatric Cardiac Surgery'
NCT02438293
Investigation of the Effectiveness of Group Voice Therapy in Children
NCT06124053
The Role of Voice Rest on Voice Outcomes Following Phonosurgery
NCT02788435
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
No laryngeal mobility disorder post cardiac surgery
No Follow up, no questionnaires and no nasofibroscopic control.
No interventions assigned to this group
Laryngeal mobility disorder post cardiac surgery
During a follow-up consultation, questionnaires will be offered to assess the child's quality of life.
Questionnaires
To explore the quality of life, two questionnaires will be submitted to the parents and the child. The first one is the pediatric version of the VHI (Voice Handicap Index), which explore, using 23 items, the functional, physical and emotional aspects of the dysphonia. The second one is the PEDI-EAT-10 (Pediatric Voice Handicap Index - Eating Assessment Tool), which explore, through 10 items (ranging from 0 to 4), the risk of aspiration and assess the impact of possible dysphagia on quality of life.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaires
To explore the quality of life, two questionnaires will be submitted to the parents and the child. The first one is the pediatric version of the VHI (Voice Handicap Index), which explore, using 23 items, the functional, physical and emotional aspects of the dysphonia. The second one is the PEDI-EAT-10 (Pediatric Voice Handicap Index - Eating Assessment Tool), which explore, through 10 items (ranging from 0 to 4), the risk of aspiration and assess the impact of possible dysphagia on quality of life.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient or parents able to understand the ins and outs of the study
Exclusion Criteria
5 Years
10 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sonia AYARI-KHALFALLAH, MD
Role: PRINCIPAL_INVESTIGATOR
Hôpital Femme Mère Enfant - Department of ENT Pediatric surgery,
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Femme Mère Enfant
Bron, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-A01701-38
Identifier Type: OTHER
Identifier Source: secondary_id
69HCL20_0505
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.